Skip to main content
OpenTrials

Clinical trial condition

Blood-Borne Infections

Explore clinical trials studying Blood-Borne Infections. Study availability and eligibility vary by location and protocol.

8,266 public trials 445 recruiting studies
Refine in advanced search Browse all conditions

Blood-Borne Infections trial results

Completed

Evaluating the Safety and Immunogenicity of HIV Clade C DNA Vaccine and MF59- or AS01B-Adjuvanted Clade C Env Protein Vaccines in Various Combinations in Healthy, HIV-Uninfected Adults

NCT02915016

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Alabama CRS Birmingham, Alabama, United States
  • Brigham and Women's Hospital Vaccine CRS (BWH VCRS) Boston, Massachusetts, United States
  • Fenway Health (FH) CRS Boston, Massachusetts, United States
  • Columbia P&S CRS New York, United States
View all 17 locations
View Trial Details
Completed

Comparing Treatments for HIV-Infected Opioid Users in an Integrated Care Effectiveness Study (CHOICES) Scale-Up

NCT03275350

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Chemically-Induced Disorders, +20 more
Locations
  • Tarzana Treatment Centers Tarzana, California, United States
  • Jackson Memorial Hospital Miami, Florida, United States
  • Ruth M. Rothstein CORE Center Chicago, Illinois, United States
  • University of Kentucky Bluegrass Care Clinic Lexington, Kentucky, United States
View Trial Details
Completed

HIV-1-Gag Conserved-Element DNA Vaccine (p24CE) Vaccine Study

NCT03560258

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Alabama CRS Birmingham, Alabama, United States
  • UCLA CARE Center CRS Los Angeles, California, United States
  • Ucsf Hiv/Aids Crs San Francisco, California, United States
  • Northwestern University CRS Chicago, Illinois, United States
View all 15 locations
View Trial Details
Completed

Evaluating the Safety and Immunogenicity of Env (A,B,C,A/E)/Gag (C) DNA and gp120 (A,B,C,A/E) Protein/GLA-SE HIV Vaccines, Given Individually or Co-administered, in Healthy, HIV-1-Uninfected Adults

NCT03409276

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Alabama CRS Birmingham, Alabama, United States
  • The Hope Clinic of the Emory Vaccine Center CRS Decatur, Georgia, United States
  • Fenway Health (FH) CRS Boston, Massachusetts, United States
  • University of Rochester Vaccines to Prevent HIV Infection CRS Rochester, New York, United States
View Trial Details
Completed

Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)

NCT02519777

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • UCLA CARE Center CRS Los Angeles, California, United States
  • UCSD Antiviral Research Center CRS San Diego, California, United States
  • Harbor-UCLA CRS Torrance, California, United States
  • Whitman-Walker Health CRS Washington D.C., District of Columbia, United States
View all 30 locations
View Trial Details
Completed

Study to Investigate the Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination for 12 Weeks in Adults With Chronic HCV Infection and Compensated Cirrhosis

NCT04112303

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations
  • Chiba University Hospital Chiba, Japan
  • Fukui-ken Saiseikai Hospital Fukui, Japan
  • Japanese Red Cross Fukuoka Hospital Fukuoka, Japan
  • Hiroshima University Hospital Institution Review Board Hiroshima, Japan
View all 22 locations
View Trial Details

Related conditions